Przegląd Epidemiologiczny - Państwowy Zakład Higieny

54 Dorota Kozielewicz, Waldemar Halota, Dorota DybowskaNr 1PIŚMIENNICTWO1. Jacobson IM, McHutchinson JG, Dusheiko G, i in. Telaprevirin combination with peginterferon and ribavirin ingenotype 1 HCV treatment-naive patients: final results ofphase 3 ADVANCE study. 61th Annual Meeting of theAmerican Association for the Study of Liver Diseases.Boston, October 30- November 3,2010, abstract 211.2. Jacobson IM, McHutchinson JG, Dusheiko G, i in. Telaprevirfor previously untreated chronic hepatitis C virusinfection. New Engl J Med 2011; 364:2405-2416.3. Sherman KE, Flamm SL, Afdhal NH, i in. Response--guided telaprevir combination treatment for hepatitisC virus infection. N Engl J Med 2011; 365:1014-1024.4. Ghany MG, Nelson DR, Strader DB, i in. An update ontreatment of genotype 1 chronic hepatitis C virus infection:2011Practice Guideline by the American Associationfor the Study of Liver Diseases. Hepatology 2011;4:1433-1444.5. Charakterystyka produktu leczniczego Incivo. http://www.ema.europa.eu6. Poordad F, McCone J, Bacon BR, i in. Boceprevir foruntreated chronic HCV genotype 1 infection. N Engl JMed 2011; 364:1195-1206.7. Charakterystyka produktu leczniczego Victrelis. Annotatedprescribing information Victrelis (boceprevir)Schering Corporation a subsidiary of Merck &Co.,INC.,Whitehouse Station, NJ 08889,USA,2011.8. Zeuzem S, Andreone P, Pol S, i in. Telaprevir for retreatmentof HCV infection. New Engl J Med 2011;364:2417-2448.9. Bacon BR, Gordon SC, Lawitz E, i in. Boceprevir forpreviously treated chronic HCV genotype 1 infection. NEngl J Med 2011; 364:1207-1217.10. European Association for the Study of the Liver. EASLClinical Practice Guidelines: Management of HepatitisC virus infection. J of Hepatol 2011; 55:245-264.11. Poordad F, McCone J, Bacon BR, i in. Boceprevir (BOC)combined with peginterferon alfa 2a/ribavirin (P/R) fortreatment naïve patients with hepatitis C virus (HCV)genotype (G) 1: SPRINT-2 final results. Hepatology2010;52(4)(Suppl): 402A, abstract LB-4.12. Foster GR, Zeuzem S, Andreone P, i in. Telaprevir-BasedTherapy in G1 HCV-Infected Patients with Prior NullResponse, Partial Response or relapse to peginterferon/ribavirin: REALIZE trial final Results. Hepatol Int 2011;5(Suppl 1):14, PS02-04.Otrzymano: 1.12.2011 r.Zaakceptowano do druku: 27.12.2011 r.Adres do korespondencji:Dr n.med. Dorota KozielewiczKlinika Chorób Zakaźnych i Hepatologii CMUMKul. Św. Floriana 1285-090 Bydgoszcztel/fax: 523255605e-mail: d.kozielewicz@wsoz.pl